Focused Therapeutic Area

All therapeutic areas face specific challenges, from patient populations to endpoints, assessment instruments and other strict study design requirements. If those needs aren’t properly understood, your goals will not be met. Therefore, it is crucial to partner with an experienced contract research organization that has a solid understanding of the clinical development process and breadth of therapeutic areas expertise.

Real World Evidence

Recent years have seen the proliferation of Real World Evidence (RWE), both in availability and importance. As early pioneers in this space, Ipsos has been running the syndicated Global Therapy Monitors (the industry’s most comprehensive portfolio of syndicated prescribing data) for over 25 years. Our RWE portfolio also includes other specialist syndicated services, and analysis and strategic consulting from our Global Evidence, Value & Access experts.

Client context

After all, RWE enables manufacturers to document the overall, longer-term value of their treatments – not just their safety & efficacy. RWE has applications throughout the product lifecycle and our clients use it in pre-launch, launch and post-launch to demonstrate the value and pricing of their drugs, assess patient and clinical pathways, identify sales opportunities and unmet needs, and more.

Solutions

Global Therapy Monitors
17,000 doctors, 400,000 patients & 25 diseases worldwide

Highly customised deliverables, fast turnaround times, global comparability of data, and the highest levels of flexibility and service from therapeutic category experts. Global Therapy Monitors include:

• ONCOLOGY
• AUTOIMMUNE
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Crohn’s Disease
  • Ulcerative Colitis
  • Psoriasis
  • Psoriatic Arthritis
  • Lupus
  • Ankylosing Spondylitis
  • Nr-AxSpA
  • Hidradenitis Suppurativa
  • Atopic Dermatitis
• VIROLOGY & LIVER DISEASES
  • HIV
  • Hepatitis B
  • Hepatitis C
  • Nonalcoholic Steatohepatitis (NASH)
• DIABETES & CARDIOVASCULAR
  • Diabetes
  • Stroke Prevention in Atrial Fibrillation
  • Pulmonary Arterial Hypertension
  • Venous Thromboembolism
  • Hyperlipidaemia
  • Hypertension
• RESPIRATORY
  • Severe Asthma
• OTHER DISEASES
  • Haemophilia
  • Cluster Headaches

Global Evidence, Value & Access

The Ipsos Healthcare Global Evidence, Value & Access Group is a specialist group that integrates evidence generation and market access strategies to support the development of product value propositions. Services include survey research, data analysis, scientific publications and observational studies; all are delivered by scientific staff with extensive career publication histories.